These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 18797080)

  • 21. Celecoxib-induced erythema multiforme-type drug eruption with a positive patch test.
    Arakawa Y; Nakai N; Katoh N
    J Dermatol; 2011 Dec; 38(12):1185-8. PubMed ID: 22103805
    [No Abstract]   [Full Text] [Related]  

  • 22. Fixed drug eruption caused by sulfaguanidine.
    Arias J; Fernández-Rivas M; Martinez M; Senent C
    Dermatology; 1994; 189(2):196-7. PubMed ID: 8075454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety of selective COX-2 inhibitors in aspirin/nonsteroidal anti-inflammatory drug-intolerant patients: comparison of nimesulide, meloxicam, and rofecoxib.
    Bavbek S; Celik G; Ozer F; Mungan D; Misirligil Z
    J Asthma; 2004 Feb; 41(1):67-75. PubMed ID: 15046380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reporting of clinical trials of analgesia.
    Katz N
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):605; author reply 606. PubMed ID: 14762388
    [No Abstract]   [Full Text] [Related]  

  • 25. New warnings for Bextra.
    FDA Consum; 2003; 37(1):5. PubMed ID: 12625292
    [No Abstract]   [Full Text] [Related]  

  • 26. Allergic skin reaction to celecoxib.
    Grob M; Scheidegger P; Wüthrich B
    Dermatology; 2000; 201(4):383. PubMed ID: 11146365
    [No Abstract]   [Full Text] [Related]  

  • 27. Nimesulide-induced hepatitis and toxic epidermal necrolysis.
    Chatterjee S; Pal J; Biswas N
    J Postgrad Med; 2008; 54(2):150-1. PubMed ID: 18480536
    [No Abstract]   [Full Text] [Related]  

  • 28. [Celebrex: confirmed effectiveness and safety (new data)].
    Nasonov EL
    Ter Arkh; 2001; 73(5):57-61. PubMed ID: 11517753
    [No Abstract]   [Full Text] [Related]  

  • 29. Serious dermatologic reaction associated with valdecoxib: report of two cases.
    Knowles SR; Phillips EJ; Wong G; Shear NH
    J Am Acad Dermatol; 2004 Dec; 51(6):1028-9. PubMed ID: 15583610
    [No Abstract]   [Full Text] [Related]  

  • 30. Acute cholestatic hepatitis induced by nimesulide.
    Romero-Gómez M; Nevado Santos M; Otero Fernández MA; Fovelo MJ; Suárez-García E; Castro Fernández M
    Liver; 1999 Apr; 19(2):164-5. PubMed ID: 10220748
    [No Abstract]   [Full Text] [Related]  

  • 31. Arthritis. Should you be taking a COX-2 inhibitor?
    Harv Health Lett; 2001 Nov; 27(1):1-3. PubMed ID: 11724695
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery.
    Ott E; Nussmeier NA; Duke PC; Feneck RO; Alston RP; Snabes MC; Hubbard RC; Hsu PH; Saidman LJ; Mangano DT; ;
    J Thorac Cardiovasc Surg; 2003 Jun; 125(6):1481-92. PubMed ID: 12830070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fixed drug eruption: topical provocation and subsequent phenomena.
    Mahboob A; Haroon TS; Iqbal Z; Iqbal F; Saleemi MA; Munir A
    J Coll Physicians Surg Pak; 2006 Dec; 16(12):747-50. PubMed ID: 17125631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutaneous vasculitis induced by cyclo-oxygenase-2 selective inhibitors.
    Drago F; Brusati C; Desirello G; Cacciapuoti M; Rebora A
    J Am Acad Dermatol; 2004 Dec; 51(6):1029-30. PubMed ID: 15583611
    [No Abstract]   [Full Text] [Related]  

  • 35. [New study of selective COX-2 inhibitors. Protecting the stomach while risking the heart? (interview by Dr. Beate Schumacher)].
    Zeidler H
    MMW Fortschr Med; 2001 Sep; 143(35-36):14. PubMed ID: 11584521
    [No Abstract]   [Full Text] [Related]  

  • 36. [Nimesulide acute hepatitis: description of 3 cases].
    Romero Gómez M; Nevado Santos M; Fobelo MJ; Castro Fernández M
    Med Clin (Barc); 1999 Sep; 113(9):357-8. PubMed ID: 10562933
    [No Abstract]   [Full Text] [Related]  

  • 37. Nimesulide and COX-2 inhibitors.
    Bakhle YS
    Lancet; 1999 Aug; 354(9180):772. PubMed ID: 10475213
    [No Abstract]   [Full Text] [Related]  

  • 38. Allergic vasculitis associated with celecoxib.
    Jordan KM; Edwards CJ; Arden NK
    Rheumatology (Oxford); 2002 Dec; 41(12):1453-5. PubMed ID: 12468830
    [No Abstract]   [Full Text] [Related]  

  • 39. Cardiovascular and renal effects of COX-2-specific inhibitors: recent insights and evolving clinical implications.
    Epstein M
    Am J Ther; 2001; 8(2):81-3. PubMed ID: 11304661
    [No Abstract]   [Full Text] [Related]  

  • 40. Tolerability of cyclooxygenase 2 inhibitors and the advisability of oral challenge.
    Rodríguez M; Enrique E; Castello JV; de Mateo JA; Roca B; Malek T
    Ann Allergy Asthma Immunol; 2003 Dec; 91(6):589. PubMed ID: 14700447
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.